Electroanatomic Mapping-Guided Radiofrequency Ablation of Adenosine Sensitive Incessant Focal Atrial Tachycardia Originating from the Non-Coronary Aortic Cusp in a Child

Incessant focal atrial tachycardia may be encountered in the pediatric age group although it is rarely seen. Ablation using radiofrequency or cryothermal energy is the preferred method for drug-resistant cases. Recently, 3D electroanatomic mapping systems have been increasingly used for mapping and ablation. In this report, we presented, for the first time, a pediatric case with incessant focal atrial tachycardia originating from the non-coronary aortic sinus and ablated using 3D electroanatomic mapping system

Evaluation of cardiac murmurs in 8647 children at primary school-age children in the Province of Malatya, Eastern Turkiye

We assessed prospectively the prevalence 01 pathologic and Innocent murmurs in childhood, to determine the efficacy of clinical evaluation, to compare the results of physical examinations performed by pediatricians and pediatric cardiologists and echocardiographic evaluations, and to contribute to the determination of the limits of echocardiography indications in children with murmurs. A number of 8647 children, aged 6.5-15 years, 4092 females, 4455 males in ten different primary schools belonging to different socioeconomic levels in Malatya, Eastern Turkey. Those children with a murmur were evaluated by a pediatric cardiologist. Chest X-ray, electrocardiography, and echocardlography were obtained in all subjects having a murmur. The results of physical examinations performed by the pediatricians and the pediatric cardiologist were compared, and the final diagnoses were reached by evaluation of chest X-ray, ECG and chocardiography. The incidence of Innocent murmurs was found to be 3.4% and that of pathological murmurs 0.54% In the population eximaned. The statistical comparison of the results revealed that pediatricians have a tendency toward Innocent murmurs in the interpretation of murmurs (p<0.05). There was not a statistically significant difference between the results of physical examinations of the pediatric cardiologist and the results of echocardlographic examination. Pediatricians can diagnose pathologic cases with a sensitivity of 63.8% whereas pediatric cardiologist could diagnose those cases with a sensitivity of 95.7% and specificity of 99.7%. Our findings support the policy that children with a cardiac murmur should be referred to a pediatric cardiologist, in order to verify clinical diagnosis

Short-Term Outcomes of Patent Ductus Arteriosus Closure With New Occlutech (R) Duct Occluder: A Multicenter Study

WOS: 000384919800011PubMed ID: 27090770Aim: Over the past 2 decades, transcatheter occlusion of patent ductus arteriosus (PDA) with coils and the duct occluders evolved to be the procedure of choice. A new device, the Occlutech PDA1 occluder (ODO) device has been designed. Herein, we aimed to evaluate the characteristics and short-term results of patients who underwent transcatheter closure of PDA using the ODO. Methods: We reviewed the clinical records of 60 patients from different centers in Turkey between December 2013 and January 2016. The medical records were reviewed for demographic characteristics and echocardiographic findings. Device size was selected on the narrowest diameter of PDA. Results: The median patient age was 2.5 years (6 months-35 years), and median PDA diameter was 2.5mm (1.2-11 mm). Fifty-eight of 60 patients (96.6%) had successful ODO implantation. The occlusion rates were 37/58 (63.7%) at the end of the procedure, 51/58 (87.9%) at 24-48 hours post-procedure, and 57/58 (98.2%) on echocardiography at a median follow-up of 7.6 months. Conclusion: Our results indicate that transcatheter closure of PDA using the ODO is effective. Larger studies and longer follow-up are required to assess whether its shape and longer length make it superior to other duct occluders in large, tubular, or window-type ducts

Short-Term Outcomes of Patent Ductus Arteriosus Closure With New Occlutech (R) Duct Occluder: A Multicenter Study

Aim: Over the past 2 decades, transcatheter occlusion of patent ductus arteriosus (PDA) with coils and the duct occluders evolved to be the procedure of choice. A new device, the Occlutech PDA1 occluder (ODO) device has been designed. Herein, we aimed to evaluate the characteristics and short-term results of patients who underwent transcatheter closure of PDA using the ODO

The characteristics of patients with COVID-19-associated pediatric vasculitis: an international, multicenter study

Objective: COVID-19 associated pediatric vasculitis other than Kawasaki disease (KD)-like vasculitis in multisystem inflammatory syndrome in children (MIS-C) is very rare. We aimed to analyze the characteristics, treatment and outcome in COVID-19-associated pediatric vasculitis (excluding KD-like vasculitis in MIS-C). Methods: The inclusion criteria were as follows: 1) &lt;18 years at vasculitis onset; 2) evidence of vasculitis; 3) evidence of SARS-CoV-2 exposure; 4) ≤3 months between SARS-CoV-2 exposure and vasculitis onset. Patients with MIS-C were excluded. Results: Forty-one patients (median age 8.3 years; M/F=1.3) were included from 14 centers and six countries. The most frequent vasculitis subtype was IgA vasculitis/Henoch Schönlein purpura (IgAV/HSP) (n=30). The median duration between SARS-CoV-2 exposure and vasculitis onset was 13 days. Skin (92.7%) and gastrointestinal (61%) involvements were the most common manifestations of vasculitis. Most patients (68.3%) received corticosteroids; while 14.6% used additional immunosuppressive drugs. Remission was achieved in all. All IgAV/HSP patients had skin manifestations while 18 (60%) and 13 (43.3%) had gastrointestinal system and renal involvement, respectively. When we compared the features of these patients with those of a pre-pandemic pediatric IgAV/HSP cohort (n=159), fever (30% vs. 5%; p&lt;0.001) and renal involvement (43.3% vs. 17.6%; p=0.002) were more common, while recovery without treatment (10% vs. 39%; p=0.002) and complete recovery (86.7% vs. 99.4%; p=0.002) were less frequent among COVID-19-associated IgAV/HSP patients. Conclusion: This is the largest cohort of children with COVID-19 associated vasculitis (excluding MIS-C). Our findings suggest a more severe disease course in COVID-19-associated pediatric IgAV/HSP patients compared to pre-pandemic patients. This article is protected by copyright. All rights reserved